All Stories

  1. The Oral Microbiome Is a Population-Scale Readout of the Exposome, Age, and Systemic Health
  2. Veillonella atypica supplementation reduces fatigue interference and increases voluntary physical activity: A randomized controlled trial with mechanistic validation in mice
  3. Specification curve analysis of the TEDDY study reveals large variation in microbiome-based T1D predictive performance
  4. Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance
  5. Adipose tissue–gut microbiome crosstalk in inflammation and thermogenesis
  6. Yanomami skin microbiome complexity challenges prevailing concepts of healthy skin
  7. Effect of Sevelamer versus Bifidobacterium longum on Insulin Sensitivity in Subjects with Obesity
  8. Single-cell RNA-seq reveals disease-specific CD8+ T cell clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in diabetic NOD mice
  9. A Lactobacillus consortium provides insights into the sleep-exercise-microbiome nexus in proof of concept studies of elite athletes and in the general population
  10. Yanomami skin microbiome complexity challenges prevailing concepts of healthy skin.
  11. Single-cell RNA-seq reveals TCR clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in NOD mice
  12. Impact of probiotic Veillonella atypica FB0054 supplementation on anaerobic capacity and lactate
  13. DNA characterization reveals potential operon-unit packaging of extracellular vesicle cargo from a gut bacterial symbiont
  14. Whole mitogenome analysis highlights demographic history and shared connections among distal Indigenous groups of Mexico Complete mitogenome sequencing from 60 Mexican Native American groups
  15. Single-cell RNA-seq reveals TCR clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in NOD mice
  16. Quantifying Shared and Unique Gene Content across 17 Microbial Ecosystems
  17. Erratum for Proctor et al., “Resources To Facilitate Use of the Altered Schaedler Flora (ASF) Mouse Model To Study Microbiome Function”
  18. Editorial: Gut microbiome, metabolites, and immune response in lupus, rheumatoid arthritis, and Sjögren syndrome
  19. Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysis
  20. Unraveling Signatures of Local Adaptation among Indigenous Groups from Mexico
  21. Resources to Facilitate Use of the Altered Schaedler Flora (ASF) Mouse Model to Study Microbiome Function
  22. Quantifying shared and unique gene content across 17 microbial ecosystems
  23. The human microbiome: A coming of age story
  24. Systematically assessing microbiome–disease associations identifies drivers of inconsistency in metagenomic research
  25. The impact of multigenerational high-fat diet feeding on the gut microbiome and host metabolism
  26. E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
  27. Using Cartesian Doubt To Build a Sequencing-Based View of Microbiology
  28. The genomic landscape of Mexican Indigenous populations brings insights into the peopling of the Americas
  29. Leveraging vibration of effects analysis for robust discovery in observational biomedical data science
  30. Gene-level metagenomic architectures across diseases yield high-resolution microbiome diagnostic indicators
  31. Reconstruction of ancient microbial genomes from the human gut
  32. Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration
  33. Activation of adenosine receptor A2a by gut symbionts promotes immune tolerance
  34. Mechanisms of microbial–neuronal interactions in pain and nociception
  35. An Immunologic Mode of Multigenerational Transmission Governs a Gut Treg Setpoint
  36. A systematic machine learning and data type comparison yields metagenomic predictors of infant age, sex, breastfeeding, antibiotic usage, country of origin, and delivery type
  37. Reply to “Is physical performance (in mice) increased by Veillonella atypica or decreased by Lactobacillus bulgaricus?”
  38. CoproID predicts the source of coprolites and paleofeces using microbiome composition and host DNA content
  39. The predictive power of the microbiome exceeds that of genome-wide association studies in the discrimination of complex human disease
  40. The Landscape of Genetic Content in the Gut and Oral Human Microbiome
  41. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences
  42. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism
  43. Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis
  44. A perfect storm: Genetics and anticommensal antibodies shore up type 1 diabetes
  45. The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response
  46. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States
  47. Correction for Zhao et al., Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
  48. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum
  49. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status
  50. Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites
  51. Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing
  52. Aether: leveraging linear programming for optimal cloud computing in genomics
  53. Aether: Leveraging Linear Programming For Optimal Cloud Computing In Genomics
  54. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
  55. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue
  56. Gut Microbiota: Small Molecules Modulate Host Cellular Functions
  57. A Microbiome Foundation for the Study of Crohn’s Disease
  58. Abstract PR01: Fusobacterium nucleatum and mutational landscape of colorectal cancer in whole-exome sequencing analysis
  59. Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease
  60. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
  61. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
  62. The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
  63. Research Highlights
  64. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
  65. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
  66. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
  67. Fusobacterium nucleatumand T Cells in Colorectal Carcinoma
  68. An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel Diseases
  69. The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
  70. Correction: Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response
  71. Inflammatory Bowel Disease as a Model for Translating the Microbiome
  72. The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
  73. The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
  74. Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response
  75. Microbes and Inflammation in Colorectal Cancer
  76. Sequence-Based Discovery ofBradyrhizobium entericain Cord Colitis Syndrome
  77. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
  78. Exploring host-microbiota interactions in animal models and humans
  79. Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome
  80. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
  81. Keystone microbiome meeting 2012: a mountain top experience
  82. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
  83. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
  84. PathSeq: software to identify or discover microbes by deep sequencing of human tissue
  85. Abstract 949: PathSeq: A comprehensive computational tool for pathogen discovery by deep sequencing of human cancer tissues
  86. The TPR-containing domain within Est1 homologs exhibits species-specific roles in telomerase interaction and telomere length homeostasis